- Home
- DDL vs PRTA Comparison
DDL vs PRTA Comparison
Compare DDL & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDL
- PRTA
- Stock Information
- Founded
- DDL 2014
- PRTA 2012
- Country
- DDL China
- PRTA Ireland
- Employees
- DDL N/A
- PRTA N/A
- Industry
- DDL Catalog/Specialty Distribution
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- DDL Consumer Discretionary
- PRTA Health Care
- Exchange
- DDL Nasdaq
- PRTA Nasdaq
- Market Cap
- DDL 450.9M
- PRTA 472.1M
- IPO Year
- DDL 2021
- PRTA N/A
- Fundamental
- Price
- DDL $1.84
- PRTA $10.75
- Analyst Decision
- DDL
- PRTA Buy
- Analyst Count
- DDL 0
- PRTA 9
- Target Price
- DDL N/A
- PRTA $16.14
- AVG Volume (30 Days)
- DDL 814.2K
- PRTA 584.3K
- Earning Date
- DDL 11-14-2025
- PRTA 11-06-2025
- Dividend Yield
- DDL N/A
- PRTA N/A
- EPS Growth
- DDL 372.99
- PRTA N/A
- EPS
- DDL 0.21
- PRTA N/A
- Revenue
- DDL $3,335,962,059.00
- PRTA $10,341,000.00
- Revenue This Year
- DDL $7.94
- PRTA N/A
- Revenue Next Year
- DDL $10.37
- PRTA $602.32
- P/E Ratio
- DDL $8.89
- PRTA N/A
- Revenue Growth
- DDL 15.14
- PRTA N/A
- 52 Week Low
- DDL $1.80
- PRTA $4.32
- 52 Week High
- DDL $4.79
- PRTA $18.78
- Technical
- Relative Strength Index (RSI)
- DDL 40.88
- PRTA 63.31
- Support Level
- DDL $1.85
- PRTA $10.34
- Resistance Level
- DDL $1.98
- PRTA $10.82
- Average True Range (ATR)
- DDL 0.07
- PRTA 0.54
- MACD
- DDL 0.00
- PRTA -0.02
- Stochastic Oscillator
- DDL 24.32
- PRTA 54.81
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.